国药现代(600420.SH)：前三季度净利润8.01亿元，同比下降16.07%

Core Viewpoint - The company reported a significant decline in both revenue and net profit for the first three quarters of 2025 compared to the previous year [1] Financial Performance - Total operating revenue for the first three quarters of 2025 was 6.92 billion, a year-on-year decrease of 19.47% [1] - Net profit attributable to shareholders was 801 million, reflecting a year-on-year decline of 16.07% [1] - Basic earnings per share stood at 0.5974 yuan [1]